Kim Janda - Director at Sorrento Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
SRNEQ
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kim Janda since 13 Mar 2025

Holdings reported by Kim Janda for Sorrento Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3,000 $2,408 $0.8027 27 Dec 2021 Direct
Non-qualified stock option 0 27 Dec 2021 Direct Common Stock

Transactions reported by Kim Janda for Sorrento Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.